Development of the vertebrate central nervous system is thought to be controlled by intricate cell-cell interactions and spatio-temporally regulated gene expressions. The details of these processes are still not fully understood. We have isolated a novel vertebrate gene, CRIM1/ Crim1, in human and mouse. Human CRIM1 maps to chromosome 2p21 close to the Spastic Paraplegia 4 locus. Crim1 is expressed in the notochord, somites,¯oor plate, early motor neurons and interneuron subpopulations within the developing spinal cord. CRIM1 appears to be evolutionarily conserved and encodes a putative transmembrane protein containing an IGF-binding protein motif and multiple cysteine-rich repeats similar to those in the BMP-associating chordin and sog proteins. Our results suggest a role for CRIM1/Crim1 in CNS development possibly via growth factor binding. q
Introduction
The generation and maintenance of complex cellular structures in the vertebrate central nervous system (CNS) begins with the initial formation of distinct cell types by intricate cascades of inductive events, followed by the formation of speci®c neuronal pathways. Cell patterning along the dorsoventral axis of the developing CNS is thought to be controlled by inductive signals derived from specialized cell groups at dorsal and ventral midline positions of the neural tube (reviewed in Tanabe and Jessell, 1996) . For example, within the caudal neural tube which gives rise to hindbrain and spinal cord, the induction of a distinct class of neurons has been shown to be controlled, at least in part, by the gradient of sonic hedgehog protein (Shh) (Ericson et al., 1997) .
Once cell patterning has commenced, cell differentiation occurs in a ventral to dorsal gradient. The motor neuron is one of the earliest neurons born in the CNS. While the ventrally-derived Shh induces motor neurons in a dosedependent manner, this induction process can also be repressed by dorsally-expressed factors. Members of bone morphogenic protein (BMP) and transforming growth factor-b (TGF-b) are expressed by the roof plate at the dorsal midline and dorsal aspect of the neural tube (Basler et al., 1993; Liem et al., 1995 Liem et al., , 1997 Lee et al., 1998) . These dorsally-derived factors have also been shown to induce distinct dorsal cell populations (Basler et al., 1993; Liem et al., 1997; Lee et al., 1998) . Therefore, it seems that the ventrally-derived and dorsally-derived factors play a critical role in setting up the early cell patterning of the neural tube including the initial induction of motor neuron cell fate (Tanabe and Jessell, 1996) . During subsequent embryonic development, functionally and anatomically distinct motor neuron subtypes begin to appear in the ventral neural tube to form characteristic motor columns (Tsuchida et al., 1994; Pfaff et al., 1996) . These neurons express unique sets of transcription factor genes, including LIM-homeodomain genes (Tsuchida et al., 1994; Pfaff et al., 1996) . The formation of distinct motor neuron subtypes appears to depend on factors from lateral plate mesoderm (Ensini et al., 1998) and retinoid-mediated signalling between early-and late-born motor neuron subtypes (Sockanathan and Jessell, 1998) . The developing motor neurons also undergo massive programmed cell death. This apoptotic wave has been studied as a model system for programmed cell death and neurodegenerative diseases (Oppenheim, 1989; Oppenheim et al., 1992; Martin, 1999) . The survival of motor neurons during this programmed cell death period appears to depend on the availability of trophic factors partly supplied by their peripheral target muscles (Oppenheim, 1989; Oppenheim et al., 1992; Caldero et al., 1998) . In addition, a variety of de®ned growth factors and neurotrophic factors have been shown to be involved in motor neuron cell death (Oppenheim, 1989; Oppenheim et al., 1992; Korsching, 1993) . These factors include neurotrophins, cilliary neurotrophic factor (CNTF), insulin-like growth factors (IGF) and members of BMP/TGF-b superfamily (Korsching, 1993; Iwasaki et al., 1997; D'Costa et al., 1998; Flanders et al., 1998) .
Despite these advances, the details of molecular mechanisms involved in early cell type speci®cation, cell survival and maintenance in the embryo and adult are still poorly understood. To understand better the molecular mechanisms underlying the normal development and pathogenesis of the vertebrate CNS, it is critical to clarify which molecules are involved in these processes. In this report, we describe the isolation and characterization of a novel vertebrate gene termed CRIM1/Crim1 (cysteine-rich motor neuron 1) in human and mouse which is expressed in a tightly regulated pattern including distinct expression in¯oor plate and motor neurons in the developing CNS in the mouse. The predicted protein structure of CRIM1/Crim1 includes characteristic multiple cysteine-rich repeats which are also found in Xenopus chordin and Drosophila short gastrulation. CRIM1/ Crim1 also contain an insulin-like growth factor binding protein motif. Taken together, this data suggests that CRIM1/Crim1 may interact with several growth factors which have been implicated in motor neuron differentiation and survival. We also show Crim1 expression sites outside of the CNS implicating additional functions for this gene product during vertebrate development.
Results

Crim1 encodes a novel cysteine-rich transmembrane protein
We initially isolated a 2.58 kb partial human CRIM1 cDNA clone from a human fetal kidney cDNA library in a yeast two-hybrid assay by virtue of its interaction with the WT1 transcription factor (Holmes et al., 1998) . A combination of fetal brain cDNA library screening and virtual transcript screening from the databases using BlastN resulted in the compilation of a 5.6 kb human Crim1 cDNA sequence which did not appear to include a start codon. 5
H RACE failed to extend this sequence due to the highly GC-rich nature of the gene. By screening a gridded human PAC library (Ioannou et al., 1994) by PCR with human CRIM1-speci®c primers, three CRIM1-containing PACs (28, 309 and E2A4) were isolated, shotgun subcloned and partially sequenced. This extended the ORF to cover a putative ATG start codon with an acceptable Kozak sequence (AGG(A)GGATG; Kozak, 1989) but lacked in-frame stop codons. Since the 5 H end sequence contains an acceptable Kozak sequence and RT-PCR from total human fetal spinal cord RNA ampli®ed a DNA fragment covering this ATG codon, we believe that the ®rst ATG in the existing 5 H end sequence is likely to be the putative start site for the translation of CRIM1 (GenBank accession no. AF167706). We have also determined 4.0 kb of cDNA for a putative murine homologue, Crim1 (GenBank accession no. AF168680), based on BlastN searches and screening a 12.5 d.p.c. whole mouse embryo-derived cDNA library using the 2.85 kb human CRIM1 cDNA sequence. The human and mouse CRIM1 cDNA sequences show an overall homology of 84%.
The human CRIM1 and mouse Crim1 cDNA sequences encode putative open reading frames of 1036 and 1029 amino acids, respectively. The existing partial mouse Crim1 protein sequence lacks the ®rst nine amino acids which are present in the human sequence (Fig. 1) . Sequence comparison of the predicted human and mouse CRIM1 proteins revealed an extremely high sequence conservation between the two species (sequence identity 89%, similarity 94%) (Fig. 1) . The CRIM1 proteins contain a predicted signal peptide sequence located at the amino terminal (Nielsen et al., 1997) , an insulin-like growth factor binding protein (IGFBP)-like domain and six highly conserved cysteine-rich repeats (Figs. 1 and 2A,B) . Towards the carboxy terminal of the proteins, there is a putative transmembrane domain (Kyte and Doolittle, 1982) and a relatively short putative cytoplasmic tail which shows no signi®cant homology to any existing proteins.
Evolutional conservation of the CRIM1 gene in vertebrates and an invertebrate
By screening the on-line database using human CRIM1 sequence, we identi®ed a C. elegans ORF (B0024.14) (Wilson et al., 1994) which represents an invertebrate homologue. This ORF shows a signi®cant homology to human and mouse CRIM1 with 45% overall similarity and 31% overall identity at the protein level (Fig. 1) . C. elegans B0024.14 is predicted to encode 6 conserved cysteine-rich repeats, and a putative transmembrane domain. This ORF appears to lack regions encoding an IGFBP-like motif and signal peptide sequence on its N-terminal end (Figs. 1 and 2A) but may represent only a partial ORF. Further evidence for evolutionary conservation comes from the observation of signals in chicken and zebra®sh via genomic Southern blotting under high stringency (data not shown). These Fig. 1 . Amino acid sequence alignment of human CRIM1, mouse Crim1 and C. elegans ORF B0024.14 proteins indicating identity between the three. The positions of the signal peptide (SP), the Insulin-like growth factor binding protein like domain (IGFBP) the six VWFC type cysteine-rich repeat motifs (CR1-6) and the putative transmembrane domain (TM) is indicated by bars. The predicted signal cleavage site for the signal peptide is shown by an arrow. Signal peptide and signal cleavage site were determined by the SignalP program (http://www.cbs.dtu.dk/ services/SignalP) (Nielsen et al., 1997) . The transmembrane domain was determined by hydrophilicity plot analysis (Kyte and Doolittle, 1982) using the MacVector hydrophilicity program. observations suggest that CRIM1 genes have an evolutionally conserved role in vertebrates and an invertebrate.
Northern blot analysis of Crim1 mRNA in adult human tissues and the developing mouse embryo
In human, a CRIM1 transcript of approximately 6.0 kb was detected in a variety of tissues including pancreas, kidney, skeletal muscle, lung, placenta, brain and heart, but not liver (Fig. 2C, bottom panel) . A very strong expression of the 6.0 kb transcript was seen in placenta. This corresponds closely to the size determined from the cDNA sequence (5.6 kb).
The temporal expression of mouse Crim1 during development was determined using a multiple stage Northern Blot with total mRNA derived from mouse embryos. Expression of a 6.2 kb (major) and 4.0 kb (minor) transcript was strongly detected in embryos from 11.5 days post coitum (d.p.c.) to 17.5 d.p.c. (Fig. 2C, top panel) . The presence of the minor transcript of 4.0 kb, which is not detected in adult human tissue-derived mRNA, raises the possibility that this transcript represents an alternate splice form or a related gene. The expression level of Crim1 increased with embryonic age, reaching peak expression between 12.5 and 13.5 d.p.c. (Fig. 2C , top panel).
Expression pattern analysis of Crim1 in the developing mouse embryo by in situ hybridization
To provide more detailed information on the spatial and temporal expression patterns of Crim1 during development, we localized the mRNA in developing mouse embryos using in situ hybridization of whole-mount preparations. Crim1 expression was ®rst detected in whole-mount preparation of 9.0 d.p.c. embryos in the central portion of the developing somites located in the rostral region of the body (Fig. 3A) . No signi®cant expression of Crim1 was detected in 7.5±8.5 d.p.c. embryos (data not shown). Crim1 expression commenced in the central nervous system weakly in the ventral region of the midbrain and hindbrain at 10.0 d.p.c. (Fig. 3B ). At this stage, the patterning gene Shh is already expressed in the¯oor plate and notochord throughout the body axis and dorso-ventral cell patterning and motor neuron induction has commenced (Echelard et (Wood et al., 1997) . Both northerns are of total RNA. al., 1993; Chiang et al., 1996) . By 11.0 d.p.c., Crim1 expression was observed in more caudal somites (Fig. 3C ). At this stage and at 11.5 d.p.c., Crim1 was also expressed in the developing lens, the ventral aspect of neural tube and a portion of the otic vesicle and developing tooth primordia ( Fig. 3C,E) . Expression in the tooth primordia continued at 13.5 d.p.c. (Fig. 3F ,G). In 13.5 d.p.c. embryos, coincident Crim1 expression was also visible in the vibrissae, nasal epithelium, lens and pinna of the ear (Fig. 3D,F±I) .
Crim1 is expressed in the developing mouse brain
A detailed expression pattern analysis of Crim1 within the developing mouse brain was investigated in bisected brain whole-mount preparations and serial cryosections. In the 11.5 d.p.c. brain, signi®cant expression of Crim1 was found in the pretectum and zona limitans in the diencephalon and the roof of the anterior hindbrain (Fig. 3E) . In the diencephalon, distinct expression of Crim1 was found in a region posterior to the optic stalk (Fig. 3E) . Crim1 expression was seen in the¯oor plate in the hindbrain and midbrain in bisected brain preparations (Fig. 3E) . In serial sections of the hindbrain at this stage, Crim1 expression in the¯oor plate appeared to overlap with that of Shh (Fig.  3J,L) . In the hindbrain, Crim1 expression was not detected in the trigeminal motor nucleus or in the trigeminal ganglia both of which express Islet-1 (Fig. 3J,K) . In 13.5 d.p.c. bisected brain preparations, strong expression of Crim1 was found in the¯oor plate of the hindbrain and midbrain, in an intermediate region of the hindbrain and the dorsal midline of the rostral end of the diencephalon (Fig. 3F ).
Expression of Crim1 in the developing mouse spinal cord
Strong expression of Crim-1 in the¯oor plate of mid and (G, open arrowheads) , the lens of the eye (H) and pinna of the ear (I) in 13.5 d.p.c. embryos. cp, commissural plate; ea, ear; ey, eye; fp,¯oor plate; os, optic stalk; ot, otic vesicle; pt, pretectum; so, somites; tg, trigeminal ganglion; tgn, trigeminal motor nucleus; tp, tooth primordia; vi, vibrissae; zl, zona limitans. Scale bars in A±F are 500 mm and in H±L 100 mm.
hindbrain led us to investigate the expression pattern of this gene in the developing mouse spinal cord by in situ hybridization of cryosections with cell type-speci®c markers which de®ne distinct neural cell populations.
The expression of Crim1 was ®rst detected in the¯oor plate in the spinal cord of 9.5 d.p.c. embryos (Fig. 4A) . At the same stage, signi®cant expression of Shh was observed in the developing¯oor plate (Fig. 4B) . At 10.5 d.p.c., motor neurons in the ventro-lateral part of spinal cord,¯oor plate and notochord expressed Crim1 (Fig. 4C) . The expression domain of Crim1 appeared to overlap well with the expression domains of an early motor neuron marker gene, Islet-1, as shown in serial sections (Fig. 4C,D ; Ericson et al., 1992) .
In older embryos, the expression pattern of Crim1 within the region of developing motor neurons became more complex. This appeared to coincide with the formation of distinct motor columns. In this study, we focused on brachial and thoracic spinal cord levels since the brachial spinal cord contains lateral motor column (LMC) and medial motor column (MMC) motor neurons whilst the thoracic spinal cord contains only MMC motor neurons as well as preganglionic motor neurons (Tsuchida et al., 1994; Pfaff et al., 1996; Ensini et al., 1998) . At 11.5 d.p.c., Crim1 was expressed in a subset of motor neurons at the dorsal and medial regions of the motor column (Fig. 4E,F) . In the thoracic spinal cord, Crim1 was expressed in the medial region of the motor column (Fig. 4I,J) . In both brachial and thoracic spinal cord, a subset of Islet-1 expressing motor neurons did not appear to express Crim1 (arrows in Fig. 4E,F,I ,J). In addition to the expression of Crim1 in motor neurons, expression was also seen in the¯oor plate at both levels of the spinal cord (Fig. 4E,I ). At 11.5 d.p.c., Crim1 expression domains did not overlap with that of Chx10 which marks a ventral interneuron population in both brachial and thoracic levels (Fig. 4G ,H,K,L; Ericson et al., 1997) .
At 13.5 d.p.c., the expression of Crim1 in motor neurons and¯oor plate continued. In addition, a very low level of Crim1 expression was observed throughout the spinal cord (Fig. 4M,Q) . In the brachial 13.5 d.p.c. spinal cord, Crim1 appeared to be expressed in the LMC motor neurons while very few motor neurons in the lateral part of the MMC expressed Crim1 (Fig. 4M,N) . At the thoracic level, the expression of Crim1 appeared to overlap with that of Islet-1-positive MMC motor neurons (Fig. 4Q,R) . Crim1 was not expressed in the preganglionic motor neurons which have migrated to the lateral horn of the thoracic spinal cord by this stage (Fig. 4Q,R) . In addition to the ventral expression of Crim1, a distinct population of cells in the intermediate region of the spinal cord expressed Crim1 at both brachial and thoracic levels (arrow heads in Fig. 4M,Q) . This intermediate region of Crim1 expression was situated dorsally to that of a distinct population of dorsal interneurons marked by Islet-1 expression (Fig.  4N ,R,P,T; Yamada et al., 1991; Liem et al., 1995; Liem et al., 1997) . No signi®cant overlap between the domains of Crim1 and Chx10-expressing ventral interneurons was observed in either brachial or thoracic spinal cord ( Fig.  4O ,P,S,T). At this stage, the Crim1 expression in the¯oor plate decreased in both brachial and thoracic levels (Fig.  4M,Q) .
At 15.5 d.p.c., widespread expression of Crim1 was observed in the spinal cord, although there appeared to be signi®cant differences in the level of expression amongst the Crim1 positive cells, with motor neurons exhibiting the highest level of expression (Fig. 4U,W) . At the brachial level, Crim1 expression in the LMC appeared lower than that at 13.5 d.p.c. (Fig. 4U,V) , whilst its expression in the MMC still appeared to coincide with that of Islet-1 (Fig.  4W,X) . By 15.5 d.p.c., the spinal cord begins to establish a distinct lamina structure in the dorsal horn where sensory axons begin to innervate according to their modality (Ozaki and Snider, 1997) . Interestingly, at this stage, Crim1 expression in the dorsal horn appeared to be much lower than that in the rest of spinal cord (Fig. 4U,W) . Again, the expression domains of Crim1 and Chx10 did not overlap signi®cantly at this stage (data not shown). The expression of Crim1 in thē oor plate was signi®cantly lower than in younger embryos and this appeared to coincide with the loss of Shh expression (data not shown, (Echelard et al., 1993) . In this study, we did not observe any detectable expression of Crim1 in the ventricular zone at all stages examined (Fig. 4) .
These observations demonstrated that the expression of Crim1 in developing spinal cord was restricted to cells outside of the ventricular zone and was initially restricted to the¯oor plate and developing motor neurons. During embryonic development, the expression of Crim1 in the spinal cord dynamically changed and exhibited unique expression domains with respect to the motor neurons. In a previous study, distinct subpopulations of motor neurons in the developing chick spinal cord have been de®ned by combinatory expression of members of LIM-homeodomain transcription factors, including Islet-1 (Tsuchida et al., 1994) . Our results would support this molecular heterogeneity within the early developing motor neurons and suggest that Crim1 may de®ne a distinct subset of these neurons.
Physical mapping and genomic structure of CRIM1
The high degree of sequence conservation between human CRIM1 and mouse Crim1 and the restricted pattern of expression in the mouse embryo suggests that Crim1 may play an important functional role in the development of the vertebrate embryo, particularly in the development of the brain and spinal cord. These observations raise the possibility that a mutation of this gene may be involved in the pathogenesis of human disease. We determined the chromosomal localization of CRIM1 by screening the UK Human Genome Mapping Project Genebridge Radiation Hybrid Panel 4. This revealed a chromosomal location for CRIM1 on human chromosome 2p21-16.3, between the genetic loci D2S1852 and D2S1736. Con®rmation of this location was determined by¯uorescence in situ hybridization (FISH). Three human genomic PAC clones containing CRIM1, clones 28, 309 (5 H end) and E2A4 (3 H end), were isolated and used in FISH analysis. Hybridization of biotin or digoxygenin-labelled CRIM1 PAC clones to human metaphase chromosomes in FISH revealed speci®c and identical¯uor-escent signals on both chromatids of the short arm of chromosome 2, in the region of p21-22, for each of the three PAC clones in a total of 104 chromosomes (Fig. 5A) .
A search of the OMIM database revealed several neurological diseases in this region. These include an autosomal dominant form of spastic paraplegia type 4 (SPG4 familial spastic paraplegia 2), hereditary essential tremor 2 (ETM2) and holoprosencephaly 2 (HPE2). HPE2 is characterized by craniofacial and brain abnormalities, including cyclopia, which is the result of failure of normal midline formation (Muenke, 1989) . SPG4 is a phenotypically heterogeneous disease, patients presenting with a range of neurological symptoms including spastic paraparesis, progressive gait dif®culties and distal axonal degeneration of spinal cord long ascending and descending tracts and motor neuron death. The autosomal dominant form of essential tremor, ETM2, is also characterized by defects of the motor system, most notably essential and variable tremor of the arms, head, legs, trunk, voice, jaw and facial muscles. Since the expression of Crim1 in the developing spinal cord makes this gene a suitable candidate for the neurological symptoms of HPE2, the localization of CRIM1 with respect to the HPE2 locus was investigated in more detail. We obtained a yeast arti®cial chromosome (YAC), 930a1 (Genome Systems), which is partially within the HPE2 minimal critical region (Schell et al., 1996) and used this to localize HPE2 using FISH analysis. Hybridization of the biotin-labelled YAC in 44 chromosomes revealed a more centromeric location for HPE2, at chromosome 2p16-21 (Fig. 5B) .
During genomic structure characterization using sequencing of shot-gun subclones of the CRIM1-containing PACs, BlastN searching of human genome updates identi®ed two large regions of human genomic sequence (NH0078I14 and NH0501O07) which cover 236314bp. Sixteen of the 17 CRIM1 exons could be positioned within these sequences (see Fig. 5C ). The annotated genomic structure of CRIM1 has been submitted to GenBank (accession no. AF168681). Exon 1 (as de®ned by the presence of the ATG) resides on both PAC 28 and 309 but not within this 236 kb region. Four STS markers could be identi®ed within this 236 kb, D2S2230, WI-16850, WI-17612 and WI-7820 (see Fig.  5C,D) . WI-17612 represents the ®nal exon of another gene, FEZ-2. The previously designated order and relative positions of markers D2S2230 and WI-7820 would suggest that the CRIM1 gene reads in the telomere to centromere direction, whereas FEZ-2 reads in the opposite direction. The marker WI-16850, contained within CRIM1 intron 14, has previously been mapped considerably centromeric to these other markers. We would suggest that this be repositioned close to WI-17612.
The four markers found within the CRIM1 gene enabled re®nement of the physical location of CRIM1 with respect to ETM2, SPG4 and HPE2 (Fig. 5D) . The physical and genetic maps would suggest a considerable distance (5 Mb) between HPE2 and CRIM1. In addition, mutations within the SIX3 gene, which lies between D2S119 and D2S391, have now been identi®ed within HPE2 patients (Wallis et al., 1999) . The gene for ETM2 has been mapped to chromosome 2p22-25 by linkage analysis with a minimal critical region between D2S2150 and D2S220 (Higgins et al., 1998) , placing it considerably telomeric to CRIM1. SPG4 has been linked to the 2p21 region with a minimal critical region between the genetic loci D2S352 and D2S367 (Scott et al., 1997) . This would place the CRIM1 ORF within 1Mb from the centromeric end of the SPG4 minimal critical region.
Discussion
We report here the cloning and initial characterization of a novel transmembrane protein containing multiple cysteine-rich repeats which may play a role in patterning within the developing central nervous system. The human and mouse CRIM1 genes encode six highly conserved cysteine-rich repeats, most similar to those found in procollagen, thrombospondin and Von Willebrand factor (Dixit et al., 1986; Hunt and Barker, 1987; Ryan and Sandell, 1990) . These have been referred to as VWFC domains (Bork, 1993) and consist of ten spaced cysteines. These domains are thought to be involved in protein±protein interactions and possible oligomerization (Hunt and Barker, 1987; Voorberg et al., 1991) . Within CRIM1, a tryptophan and a proline are present at ®xed positions within each repeat (CX12-16WX4CX2CXCX6CX4CX4-6CX9-11CCPXC) as is also seen in C. elegans B0024.14. The function of such repeats in procollagen is revealed by the alternative splicing of Type IIA versus Type IIB procollagen. Type IIA procollagen has been shown to bind to BMP-2 and TGF-b1, whereas Type IIB procollagen does not (Zhu et al., 1999) . This difference is due to the presence or absence of exon 2 (69 amino acids) which encodes a single VWFC domain. This domain is very similar (36% identity, 46% similarity, with no gaps over 55 amino acids) to the human CRIM1 cysteine rich repeats. Therefore, it is also possible that CRIM1 may directly interact with BMPs and/or similar proteins via the cysteine-rich repeats.
3.1. Cysteine-rich motifs are highly conserved in chordin and short gastrulation Two proteins have been identi®ed which also contain multiple cysteine rich repeats; Xenopus chordin and Drosophila short gastrulation (Francois et al., 1994; Sasai et al., 1994) . Chordin (chd) and short gastrulation (sog) have been shown to be functionally homologous genes whose functions are required for normal embryonic axis formation in the frog and dorso-ventral axis formation in Drosophila by directly interacting with bone morphogenetic protein 4 (BMP-4) and its Drosophila homologue decapentaplegic (Francois et al., 1994; Francois and Bier, 1995; Sasai et al., 1995) . The direct binding of Chd to BMP-4 has been demonstrated (Piccolo et al., 1996) , although the exact motifs required for interaction with BMPs remain to be elucidated.
IGF-binding protein motif suggests a possible interaction with IGFs
The N-terminal end of the CRIM1 proteins contain another cysteine rich region closely related to the putative insulin-like growth factor (IGF)-binding regions of the IGFbinding proteins (IGFBP). The IGFBP superfamily is a heterogeneous group of proteins which act to regulate the biological action of IGFs, often with relatively low levels of sequence homology other than within the N-terminal and Cterminal regions. The N-terminal region of these proteins contain an IGFBP motif (GCGCCXXC) (Kim et al., 1997) as part of a cluster of 10±12 highly conserved cysteines, of which CRIM1 has 10. Many IGFBPs were previously ascribed to other gene families and have subsequently been shown to interact with IGF-I and/or IGF-II in vitro. CRIM1 is most similar to IGFBP-7, a newly identi®ed, lowaf®nity member of the IGFBP superfamily, formerly referred to as MAC25 (Murphy et al., 1993; Oh et al., 1996) . IGFBP-7 contains the N-terminal conserved sequence, including the same 10 cysteines as CRIM1, but low sequence homology to other IGFBPs in the C-terminal region. IGFBP-7 has been shown to bind both IGF-I and IGF-II in vitro, but with 5±25-fold lower af®nity than the other IGFBPs (Oh et al., 1996; Kim et al., 1997) . IGFBP-7, together with several other IGFBPs, is also a high-af®nity insulin binding protein, modulating the binding of insulin to its receptor and subsequently inhibiting the initial stages of insulin action (Yamanaka et al., 1997) . From the high level of amino acid identity between CRIM1 and IGFBP-7 in the N-terminal region, we would predict that CRIM1 will also bind the IGFs and perhaps insulin in vitro and may also constitute a new low-af®nity member of the IGFBP superfamily.
CRIM1 may function in motor neuron development and survival
Receptors for many members of the TGF-b superfamily, including the BMPs, have been described (Ebendal et al., 1998) . However, it appears that there are many proteins other than these receptors that BMPs can interact with to elicit a physiological response. For example, Noggin has been shown to directly bind BMP-4 (McMahon et al., 1998) . Inactivation of Noggin, which is secreted by the notochord and¯oor plate in the early developing neural tube, leads to a progressive loss of ventral neurons (McMahon et al., 1998) . By analogy, an interaction between Crim1 and BMPs/TGFbs may be functionally important for early CNS development. In the developing neural tube, BMPs and members of TGF-b superfamily are expressed in the dorsal midline and dorsal aspect of the neural tube (Basler et al., 1993; Liem et al., 1997) . Dorsalin-1, a member of the TGFb superfamily can induce distinct dorsal neural cell types while repressing motor neuron induction in the ventral neural tube (Basler et al., 1993; Liem et al., 1997) . Crim1 expression in the¯oor plate and early developing motor neurons in the ventral aspect of early developing spinal cord may have a role in generating distinct cell populations in the ventral spinal cord via an interaction with the dorsally-derived BMPs and TGF-b-like factors.
In addition to cell type-speci®cation, Crim1 may also be involved in motor neuron survival. Members of the TGF-b superfamily have been implicated in motor neuron cell survival in the embryo and following trauma in mature animals (Yin et al., 1994; Iwasaki et al., 1997) . IGFs have also been previously implicated in motor neuron axon elongation, cell survival and synapse formation Neff et al., 1993; D'Costa et al., 1998) . The presence of Crim1 on or near the developing motor neuron during the naturally occurring motor neuron cell death period therefore raises the possibility that Crim1 is involved in motor neuron survival during later stages of development by interacting with members of the BMP and TGF-b superfamily and/or IGFs.
Wholemount and section in situ hybridization
Mouse embryos were obtained from pregnant CD1 or Swiss mice. The stage of embryos was determined by designating noon on the day of plug as 0.5 d.p.c. In addition, stereotyped limb shapes characteristic for each developmental stage were used as a guide (Rugh, 1968) .
Whole mouse embryos or portions of brain and spinal cord were dissected in ice-cold 10 mM phosphate buffered saline (PBS) or Lebovidz-15 (L-15, Gibco BRL) culture medium and ®xed in 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer overnight at 48C. Whole-mount in situ hybridization was performed as previously described (Holmes et al., 1998) with minor modi®cations. Sense and antisense RNA probes were labelled with digoxygenin (DIG; Boehringer-Mannheim). Hybridization and washing steps were carried out at 658C. Templates for DIG-labelled RNA probes were as follows: mouse probes: Crim1 (Crim-1 cDNA clone, nucleotides 1541-3378), Islet-1 (dbEST Id 579911), Sonic hedgehog (Shh; subclone, nucleotides 36-678, of pShh-N clone), Chx10 (Burrill et al., 1997) . Section in situ hybridization was performed on serial 15 mm cryostat sections of fresh-frozen or PFA-®xed mouse embryos as described previously (Tsuchida et al., 1994) . Photographs of wholemounts were taken using a Leica MZ8 stereomicroscope/MPS48 photomicrographic system with Kodak Elite II ®lm. The serially labelled sections were photographed using an Olympus AX70 compound microscope. Merged images were created by scanning 35 mm slides for all three markers from serial sections of a given stage and spinal cord level using a Nikon LS-1000 scanner and in Adobe Photoshop 5, reversing the images and placing these into the separate channels of a single RGB colour ®gure. Serial sections were aligned according to the position of the¯oor plate and outline of the spinal cord rather than the skin.
Radiation-reduced hybrid panel mapping
Using the alignment of the human and mouse CRIM1 sequences, the human-speci®c PCR primers 3 H PCR 1F and 3
H PCR 1R within the 3 H untranslated region of the gene were used to screen the UK Human Genome Mapping Project Genebridge Radiation Hybrid Panel 4. PCR was performed in a 20 ml volume with 125 ng of each primer (196 bp product). A 10ml sample of PCR product was analysed by electrophoresis through 2% agarose and each sample was scored as either blank (0), positive (1) or unclear (2). The resultant code was submitted to the HGMP for pairwise analysis. A LOD score of greater than 15 to the closest genetic marker was considered statistically signi®-cant.
Fluorescence in situ hybridization analysis
CRIM1 chromosomal location was also con®rmed by the isolation of CRIM1 PAC clones for use in¯uorescence in situ hybridization (FISH). PAC and YAC genomic clones labelled with biotin or digoxygenin by nick translation using the BioNick labelling system (Life Technologies) on synchronized, peripheral human metaphase chromosomes. Chromosome preparation and FISH conditions were performed as previously described (Wicking et al., 1995) . The FITC signal on propidium iodide stained chromosomes in one colour FISH was analysed using a Zeiss Axioskop uorescent microscope equipped with a dual-laser Bio-Rad MRC 600 confocal laser scanner. In addition, two colour FISH was performed using two PAC probes, one at the 5 H end of the gene, the other at the 3 H end, in the same hybridization. In two colour FISH, DAPI stained chromosomes double labelled with rhodamine and FITC probes were analysed directly on an Olympus¯uorescent microscope and images captured on a digital DCC camera and overlayed using Adobe Photoshop 5.
